{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:14:08Z","timestamp":1793751248378,"version":"4.6.1"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-02072977"],"award-info":[{"award-number":["RS-2025-02072977"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2025-02072977"],"award-info":[{"award-number":["RS-2025-02072977"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00449435"],"award-info":[{"award-number":["RS-2024-00449435"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04379-1","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:35:26Z","timestamp":1775730926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["EphB4-decorated biomimetic nanoparticles enhance osteoclast targeting and therapeutic effect in osteoporosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Anoop Puthiyoth","family":"Dayanandan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woong Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshie","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"4379_CR1","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.3390\/molecules26195905","volume":"26","author":"S Adepu","year":"2021","unstructured":"Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26:5905. https:\/\/doi.org\/10.3390\/molecules26195905.","journal-title":"Molecules"},{"key":"4379_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.reactfunctpolym.2010.09.008","volume":"71","author":"B Albarran","year":"2011","unstructured":"Albarran B, Hoffman AS, Stayton PS. Efficient intracellular delivery of a pro-apoptotic peptide with a pH-responsive carrier. React Funct Polym. 2011;71:261\u20135. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2010.09.008.","journal-title":"React Funct Polym"},{"key":"4379_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1016212804288","volume":"12","author":"GL Amidon","year":"1995","unstructured":"Amidon GL, Lennern\u00e4s H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413\u201320. https:\/\/doi.org\/10.1023\/A:1016212804288.","journal-title":"Pharm Res"},{"key":"4379_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","volume":"14","author":"A Albanese","year":"2012","unstructured":"Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1\u201316. https:\/\/doi.org\/10.1146\/annurev-bioeng-071811-150124.","journal-title":"Annu Rev Biomed Eng"},{"key":"4379_CR5","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1039\/C0JM03851B","volume":"21","author":"Q He","year":"2011","unstructured":"He Q, Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem. 2011;21:5845\u201355. https:\/\/doi.org\/10.1039\/C0JM03851B.","journal-title":"J Mater Chem"},{"key":"4379_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0168-3659(95)00164-6","volume":"39","author":"JC Leroux","year":"1996","unstructured":"Leroux JC, All\u00e9mann E, De Jaeghere F, Doelker E, Gurny R. Biodegradable nanoparticles from sustained release formulations to improved site specific drug delivery. J Control Release. 1996;39:339\u201350. https:\/\/doi.org\/10.1016\/0168-3659(95)00164-6.","journal-title":"J Control Release"},{"key":"4379_CR7","doi-asserted-by":"publisher","unstructured":"Sykes EA, Dai Q, Sarsons CD, Chen J, Rocheleau JV, Hwang DM, Zheng G, Cramb DT, Rinker KD, Chan WCW. Tailoring nanoparticle designs to target cancer based on tumor pathophysiology, Proc. Natl. Acad. Sci. U.S.A. 113 (2016) E1142\u2013E1151. https:\/\/doi.org\/10.1073\/pnas.1521265113","DOI":"10.1073\/pnas.1521265113"},{"key":"4379_CR8","doi-asserted-by":"publisher","unstructured":"Park H, Cho WJ, Kim J, Choi H, Baek I, Kim Y, Kim D, Kim BJ, Arai Y, Lee SH. Stepwise administration of bone-targeted lipid nanoparticles encapsulating valproic acid and TUDCA facilitates in vivo direct reprogramming for osteoporosis treatment. Tissue Eng Regen Med. 2025;1\u20135. https:\/\/doi.org\/10.1007\/s13770-025-00738-5.","DOI":"10.1007\/s13770-025-00738-5"},{"key":"4379_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40824-023-00413-7","volume":"27","author":"AP Dayanandan","year":"2023","unstructured":"Dayanandan AP, Cho WJ, Kang H, Bello AB, Kim BJ, Arai Y, Lee SH. Emerging nano-scale delivery systems for the treatment of osteoporosis. Biomater Res. 2023;27:68. https:\/\/doi.org\/10.1186\/s40824-023-00413-7.","journal-title":"Biomater Res"},{"key":"4379_CR10","unstructured":"Bai L, Song P, Su J. 2023. Bioactive elements manipulate bone regeneration. Biomaterials Translational, 4(4), p.248."},{"key":"4379_CR11","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","volume":"30","author":"SA Kulkarni","year":"2013","unstructured":"Kulkarni SA, Feng SS. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res. 2013;30:2512\u201322. https:\/\/doi.org\/10.1007\/s11095-012-0958-3.","journal-title":"Pharm Res"},{"key":"4379_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1109\/TNB.2003.820277","volume":"3","author":"AK Gupta","year":"2004","unstructured":"Gupta AK, Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobiosci. 2004;3:66\u201373. https:\/\/doi.org\/10.1109\/TNB.2003.820277.","journal-title":"IEEE Trans Nanobiosci"},{"key":"4379_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11051-008-9357-4","volume":"10","author":"L Gao","year":"2008","unstructured":"Gao L, Zhang D, Chen M. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res. 2008;10:845\u201362. https:\/\/doi.org\/10.1007\/s11051-008-9357-4.","journal-title":"J Nanopart Res"},{"key":"4379_CR14","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1021\/nn201950e","volume":"5","author":"S Tenzer","year":"2011","unstructured":"Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, Sirirattanapan J. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano. 2011;5:7155\u201367. https:\/\/doi.org\/10.1021\/nn201950e.","journal-title":"ACS Nano"},{"key":"4379_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11837-006-0147-0","volume":"58","author":"AS Karakoti","year":"2006","unstructured":"Karakoti AS, Hench LL, Seal S. The potential toxicity of nanomaterials \u2014 the role of surfaces. JOM. 2006;58:77\u201382. https:\/\/doi.org\/10.1007\/s11837-006-0147-0.","journal-title":"JOM"},{"key":"4379_CR16","doi-asserted-by":"publisher","unstructured":"Ezike T.C., Okpala U.S., Onoja U.L., Nwike P.C., Ezeako E.C., Okpara J.O., Okoroafor C.C., Eze S.C., Kalu O.L., Odoh E.C., Nwadike U. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17488.","DOI":"10.1016\/j.heliyon.2023.e17488"},{"key":"4379_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.msec.2017.04.049","volume":"78","author":"Y He","year":"2017","unstructured":"He Y, Liang S, Long M, Xu H. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel. Mater Sci Eng C. 2017;78:12\u20137. https:\/\/doi.org\/10.1016\/j.msec.2017.04.049.","journal-title":"Mater Sci Eng C"},{"key":"4379_CR18","doi-asserted-by":"crossref","unstructured":"Li M, Yu B, Wang S, Zhou F, Cui J, Su J. 2023. Microenvironment-responsive nanocarriers for targeted bone disease therapy. Nano Today, 50, p.101838.","DOI":"10.1016\/j.nantod.2023.101838"},{"key":"4379_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117007","author":"N Hasan","year":"2023","unstructured":"Hasan N, Imran M, Jain D, Jha SK, Nadaf A, Chaudhary A, Rafiya K, Jha LA, Almalki WH, Mohammed Y, Kesharwani P. Advanced targeted drug delivery by bioengineered white blood cell-membrane camouflaged nanoparticulate delivery nanostructures. Environ Res. 2023. https:\/\/doi.org\/10.1016\/j.envres.2023.117007.","journal-title":"Environ Res"},{"key":"4379_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/ph15020157","volume":"15","author":"Y Ren","year":"2022","unstructured":"Ren Y, Miao C, Tang L, Liu Y, Ni P, Gong Y, Li H, Chen F, Feng S. Homotypic cancer cell membranes camouflaged nanoparticles for targeting drug delivery and enhanced chemo-photothermal therapy of glioma. Pharmaceuticals. 2022;15:157. https:\/\/doi.org\/10.3390\/ph15020157.","journal-title":"Pharmaceuticals"},{"key":"4379_CR21","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1021\/acs.nanolett.0c01503","volume":"20","author":"X Xie","year":"2020","unstructured":"Xie X, Hu X, Li Q, Yin M, Song H, Hu J, Wang L, Fan C, Chen N. Unraveling cell-type-specific targeted delivery of membrane-camouflaged nanoparticles with plasmonic imaging. Nano Lett. 2020;20:5228\u201335. https:\/\/doi.org\/10.1021\/acs.nanolett.0c01503.","journal-title":"Nano Lett"},{"key":"4379_CR22","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1021\/acsnano.2c00893","volume":"16","author":"Y Miao","year":"2022","unstructured":"Miao Y, Yang Y, Guo L, Chen M, Zhou X, Zhao Y, Nie D, Gan Y, Zhang X. Cell membrane-camouflaged nanocarriers with biomimetic deformability of erythrocytes for ultralong circulation and enhanced cancer therapy. ACS Nano. 2022;16:6527\u201340. https:\/\/doi.org\/10.1021\/acsnano.2c00893.","journal-title":"ACS Nano"},{"key":"4379_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12951-020-00738-8","volume":"19","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Sun X, Wu B, Shang Y, Huang X, Dong H, Liu H, Chen W, Gui R, Li J. Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma. J Nanobiotechnol. 2021;19:8. https:\/\/doi.org\/10.1186\/s12951-020-00738-8.","journal-title":"J Nanobiotechnol"},{"key":"4379_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12951-021-01082-1","volume":"19","author":"M Li","year":"2021","unstructured":"Li M, Gao X, Lin C, Shen A, Luo J, Ji Q, Wu J, Wang P. An intelligent responsive macrophage cell membrane-camouflaged mesoporous silicon nanorod drug delivery system for precise targeted therapy of tumors. J Nanobiotechnol. 2021;19:336. https:\/\/doi.org\/10.1186\/s12951-021-01082-1.","journal-title":"J Nanobiotechnol"},{"key":"4379_CR25","doi-asserted-by":"publisher","first-page":"9610","DOI":"10.1021\/acsami.6b00853","volume":"8","author":"M Xuan","year":"2016","unstructured":"Xuan M, Shao J, Dai L, Li J, He Q. Macrophage cell membrane camouflaged Au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy. ACS Appl Mater Interfaces. 2016;8:9610\u20138. https:\/\/doi.org\/10.1021\/acsami.6b00853.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4379_CR26","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/IJN.S288636","volume":"16","author":"J Wang","year":"2021","unstructured":"Wang J, Gu X, Ouyang Y, Chu L, Xu M, Wang K, Tong X. Engineering of neutrophil membrane camouflaging nanoparticles realizes targeted drug delivery for amplified antitumor therapy. Int J Nanomed. 2021;16:1175\u201387. https:\/\/doi.org\/10.2147\/IJN.S288636.","journal-title":"Int J Nanomed"},{"key":"4379_CR27","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1021\/nl500618u","volume":"14","author":"RH Fang","year":"2014","unstructured":"Fang RH, Hu CMJ, Luk BT, Gao W, Copp JA, Tai Y, O\u2019Connor DE, Zhang L. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14:2181\u20138. https:\/\/doi.org\/10.1021\/nl500618u.","journal-title":"Nano Lett"},{"key":"4379_CR28","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.3390\/molecules26113428","volume":"26","author":"C Zhu","year":"2021","unstructured":"Zhu C, Ma J, Ji Z, Shen J, Wang Q. Recent advances of cell membrane coated nanoparticles in treating cardiovascular disorders. Molecules. 2021;26:3428. https:\/\/doi.org\/10.3390\/molecules26113428.","journal-title":"Molecules"},{"key":"4379_CR29","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.7150\/thno.23654","volume":"8","author":"L Jing","year":"2018","unstructured":"Jing L, Qu H, Wu D, Zhu C, Yang Y, Jin X, Zheng J, Shi X, Yan X, Wang Y. Platelet-camouflaged nanococktail: simultaneous inhibition of drug-resistant tumor growth and metastasis via a cancer cells and tumor vasculature dual-targeting strategy. Theranostics. 2018;8:2683\u201395. https:\/\/doi.org\/10.7150\/thno.23654.","journal-title":"Theranostics"},{"key":"4379_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41392-024-01859-4","volume":"9","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu Q, Wang M, Li L, Yu Y, Pan M, Hu D, Chu B, Qu Y, Qian Z. Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer, Signal Transduct. Target Ther. 2024;9:158. https:\/\/doi.org\/10.1038\/s41392-024-01859-4.","journal-title":"Target Ther"},{"key":"4379_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"A Klibanski","year":"2001","unstructured":"Klibanski A, Adams-Campbell L, Bassford T, Blair SN, Boden SD, Dickersin K, Gifford DR, Glasse L, Goldring SR, Hruska K, Johnson SR. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785\u201395. https:\/\/doi.org\/10.1001\/jama.285.6.785.","journal-title":"JAMA"},{"key":"4379_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337\u201342. https:\/\/doi.org\/10.1038\/nature01658.","journal-title":"Nature"},{"key":"4379_CR33","doi-asserted-by":"publisher","first-page":"116353","DOI":"10.1016\/j.bone.2022.116353","volume":"159","author":"N Takegahara","year":"2022","unstructured":"Takegahara N, Kim H, Choi Y. RANKL biology Bone. 2022;159:116353. https:\/\/doi.org\/10.1016\/j.bone.2022.116353.","journal-title":"RANKL biology Bone"},{"key":"4379_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fncel.2017.00040","volume":"11","author":"Z Li","year":"2017","unstructured":"Li Z, Hao J, Duan X, Wu N, Zhou Z, Yang F, Li J, Zhao Z, Huang S. The role of semaphorin 3A in bone remodeling. Front Cell Neurosci. 2017;11:40. https:\/\/doi.org\/10.3389\/fncel.2017.00040.","journal-title":"Front Cell Neurosci"},{"key":"4379_CR35","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/cdd.2015.14","volume":"22","author":"L Wang","year":"2015","unstructured":"Wang L, Liu S, Zhao Y, Liu D, Liu Y, Chen C, Karray S, Shi S, Jin Y. Osteoblast-induced osteoclast apoptosis by fas ligand\/FAS pathway is required for maintenance of bone mass. Cell Death Differ. 2015;22:1654\u201364. https:\/\/doi.org\/10.1038\/cdd.2015.14.","journal-title":"Cell Death Differ"},{"key":"4379_CR36","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/jbmr.2196","volume":"29","author":"Y Wang","year":"2014","unstructured":"Wang Y, Menendez A, Fong C, ElAlieh HZ, Chang W, Bikle DD. Ephrin B2\/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation. J Bone Min Res. 2014;29:1900\u201313. https:\/\/doi.org\/10.1002\/jbmr.2196.","journal-title":"J Bone Min Res"},{"key":"4379_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/ijms23179846","volume":"149","author":"T Ono","year":"2018","unstructured":"Ono T, Nakashima T. Recent advances in osteoclast biology, Histochem. Cell Biol. 2018;149:325\u201341. https:\/\/doi.org\/10.3390\/ijms23179846.","journal-title":"Cell Biol"},{"key":"4379_CR38","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1038\/s41467-018-06898-4","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Xie L, Wang M, Xiong Q, Guo Y, Liang Y, Li J, Sheng R, Deng P, Wang Y, Zheng R. Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun. 2018;9:4772. https:\/\/doi.org\/10.1038\/s41467-018-06898-4.","journal-title":"Nat Commun"},{"key":"4379_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fimmu.2019.00629","volume":"10","author":"C Sobacchi","year":"2019","unstructured":"Sobacchi C, Menale C, Villa A. The RANKL-RANK axis: A bone to thymus round trip. Front Immunol. 2019;10:629. https:\/\/doi.org\/10.3389\/fimmu.2019.00629.","journal-title":"Front Immunol"},{"key":"4379_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L. Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473:139\u201346. https:\/\/doi.org\/10.1016\/j.abb.2008.03.018.","journal-title":"Arch Biochem Biophys"},{"key":"4379_CR41","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrg1122","volume":"4","author":"SL Teitelbaum","year":"2003","unstructured":"Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003;4:638\u201349. https:\/\/doi.org\/10.1038\/nrg1122.","journal-title":"Nat Rev Genet"},{"key":"4379_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","volume":"4","author":"C Zhao","year":"2006","unstructured":"Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 2006;4:111\u201321. https:\/\/doi.org\/10.1016\/j.cmet.2006.05.012.","journal-title":"Cell Metab"},{"key":"4379_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00418-018-1712-7","volume":"151","author":"A Kaur","year":"2019","unstructured":"Kaur A, Xing W, Mohan S, Rundle CH. Changes in ephrin gene expression during bone healing identify a restricted repertoire of ephrins mediating fracture repair, Histochem. Cell Biol. 2019;151:43\u201355. https:\/\/doi.org\/10.1007\/s00418-018-1712-7.","journal-title":"Cell Biol"},{"key":"4379_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3892\/etm.2013.1357","volume":"7","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Wang XC, Bao XF, Hu M, Yu WX. Effects of Porphyromonas gingivalis lipopolysaccharide on osteoblast\u2013osteoclast bidirectional EphB4\u2013ephrinB2 signaling. Exp Ther Med. 2014;7:80\u20134. https:\/\/doi.org\/10.3892\/etm.2013.1357.","journal-title":"Exp Ther Med"},{"key":"4379_CR45","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jbmr.1821","volume":"28","author":"A Arthur","year":"2013","unstructured":"Arthur A, Panagopoulos RA, Cooper L, Menicanin D, Parkinson IH, Codrington JD, Vandyke K, Zannettino AC, Koblar SA, Sims NA, Matsuo K. EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair. J Bone Min Res. 2013;28:926\u201335. https:\/\/doi.org\/10.1002\/jbmr.1821.","journal-title":"J Bone Min Res"},{"key":"4379_CR46","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1089\/ten.tea.2015.0012","volume":"21","author":"F Zhang","year":"2015","unstructured":"Zhang F, Zhang Z, Sun D, Dong S, Xu J, Dai F. EphB4 promotes osteogenesis of CTLA4-modified bone marrow-derived mesenchymal stem cells through cross talk with Wnt pathway in xenotransplantation. Tissue Eng Part A. 2015;21:2404\u201316. https:\/\/doi.org\/10.1089\/ten.tea.2015.0012.","journal-title":"Tissue Eng Part A"},{"key":"4379_CR47","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.actbio.2015.12.013","volume":"32","author":"L Forte","year":"2016","unstructured":"Forte L, Torricelli P, Boanini E, Gazzano M, Rubini K, Fini M, Bigi A. Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast\u2013osteoclast\u2013endothelial cell co-culture study. Acta Biomater. 2016;32:298\u2013308. https:\/\/doi.org\/10.1016\/j.actbio.2015.12.013.","journal-title":"Acta Biomater"},{"key":"4379_CR48","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bbrc.2017.01.179","volume":"484","author":"F Zhou","year":"2017","unstructured":"Zhou F, Shen Y, Liu B, Chen X, Wan L, Peng D. Gastrodin inhibits osteoclastogenesis via down-regulating the NFATc1 signaling pathway and stimulates osseointegration in vitro. Biochem Biophys Res Commun. 2017;484:820\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2017.01.179.","journal-title":"Biochem Biophys Res Commun"},{"key":"4379_CR49","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.3748\/wjg.v19.i38.6398","volume":"19","author":"E Sticov\u00e1","year":"2013","unstructured":"Sticov\u00e1 E, Jirsa M. New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol. 2013;19:6398\u2013407. https:\/\/doi.org\/10.3748\/wjg.v19.i38.6398.","journal-title":"World J Gastroenterol"},{"key":"4379_CR50","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3389\/fphar.2017.00887","volume":"8","author":"J \u010cvorovi\u0107","year":"2017","unstructured":"\u010cvorovi\u0107 J, Passamonti S. Membrane transporters for bilirubin and its conjugates: a systematic review. Front Pharmacol. 2017;8:887. https:\/\/doi.org\/10.3389\/fphar.2017.00887.","journal-title":"Front Pharmacol"},{"key":"4379_CR51","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1172\/jci106184","volume":"48","author":"PD Berk","year":"1969","unstructured":"Berk PD, Howe RB, Bloomer JR, Berlin NI. Studies of bilirubin kinetics in normal adults. J Clin Investig. 1969;48:2176\u201390. https:\/\/doi.org\/10.1172\/jci106184.","journal-title":"J Clin Investig"},{"key":"4379_CR52","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0021-9258(19)51154-1","volume":"184","author":"IM London","year":"1950","unstructured":"London IM, West R, Shemin D, Rittenberg D. On the origin of bile pigment in normal man. J Biol Chem. 1950;184:351\u20138.","journal-title":"J Biol Chem"},{"key":"4379_CR53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5483\/bmbrep.2017.50.2.220","volume":"50","author":"SU Bak","year":"2017","unstructured":"Bak SU, Kim S, Hwang HJ, Yun JA, Kim WS, Won MH, Kim JY, Ha KS, Kwon YG, Kim YM. Heme oxygenase-1 (HO-1)\/carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-\u03baB activation. BMB Rep. 2017;50:103. https:\/\/doi.org\/10.5483\/bmbrep.2017.50.2.220.","journal-title":"BMB Rep"},{"key":"4379_CR54","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jcb.23372","volume":"113","author":"E Sakai-Sugawara","year":"2012","unstructured":"Sakai-Sugawara E, Shimada-Sugawara M, Nishishita K, Fukuma Y, Naito M, Okamoto K, Nakayama K, Tsukuba T. Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis. J Cell Biochem. 2012;113:486\u201398. https:\/\/doi.org\/10.1002\/jcb.23372.","journal-title":"J Cell Biochem"},{"key":"4379_CR55","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1096\/fj.05-4095fje","volume":"19","author":"J Zwerina","year":"2005","unstructured":"Zwerina J, Tzima S, Hayer S, Redlich K, Hoffmann O, Hanslik-Schnabel B, Smolen JS, Kollias G, Schett G. Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption. FASEB J. 2005;19:2011\u20133. https:\/\/doi.org\/10.1096\/fj.05-4095fje.","journal-title":"FASEB J"},{"key":"4379_CR56","doi-asserted-by":"publisher","first-page":"e0191192","DOI":"10.1371\/journal.pone.0191192","volume":"13","author":"Y Ohyama","year":"2018","unstructured":"Ohyama Y, Ito J, Kitano VJ, Shimada J, Hakeda Y. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors. PLoS ONE. 2018;13:e0191192. https:\/\/doi.org\/10.1371\/journal.pone.0191192.","journal-title":"PLoS ONE"},{"key":"4379_CR57","doi-asserted-by":"publisher","first-page":"256","DOI":"10.18632\/aging.101158","volume":"9","author":"S Maria","year":"2017","unstructured":"Maria S, Swanson MH, Enderby LT, D\u2019Amico F, Enderby B, Samsonraj RM, Dudakovic A, van Wijnen AJ, Witt-Enderby PA. Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D\u2083 and vitamin K\u2082 (MK-7) on bone density, bone marker turnover and health-related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures. Aging. 2017;9:256. https:\/\/doi.org\/10.18632\/aging.101158.","journal-title":"Aging"},{"key":"4379_CR58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijpharm.2007.06.011","volume":"346","author":"A Budhian","year":"2008","unstructured":"Budhian A, Siegel SJ, Winey KI. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int J Pharm. 2008;346:151\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.06.011.","journal-title":"Int J Pharm"},{"key":"4379_CR59","doi-asserted-by":"publisher","first-page":"181457","DOI":"10.1098\/rsos.181457","volume":"5","author":"S Wan","year":"2018","unstructured":"Wan S, Zhang L, Quan Y, Wei K. Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy. R Soc Open Sci. 2018;5:181457. https:\/\/doi.org\/10.1098\/rsos.181457.","journal-title":"R Soc Open Sci"},{"key":"4379_CR60","doi-asserted-by":"publisher","first-page":"33234","DOI":"10.1038\/srep33234","volume":"6","author":"HI Hung","year":"2016","unstructured":"Hung HI, Klein OJ, Peterson SW, Rokosh SR, Osseiran S, Nowell NH, Evans CL. PLGA nanoparticle encapsulation reduces toxicity while retaining the therapeutic efficacy of EtNBS-PDT in vitro. Sci Rep. 2016;6:33234. https:\/\/doi.org\/10.1038\/srep33234.","journal-title":"Sci Rep"},{"key":"4379_CR61","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bbagrm.2014.08.002","volume":"1839","author":"C Dou","year":"2014","unstructured":"Dou C, Zhang C, Kang F, Yang X, Jiang H, Bai Y, Xiang J, Xu J, Dong S. miR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation. BBA Gene Regul Mech. 2014;1839:1084\u201396. https:\/\/doi.org\/10.1016\/j.bbagrm.2014.08.002.","journal-title":"BBA Gene Regul Mech"},{"key":"4379_CR62","doi-asserted-by":"publisher","first-page":"16491","DOI":"10.1038\/s41598-022-20351-z","volume":"12","author":"J St\u00fcrznickel","year":"2022","unstructured":"St\u00fcrznickel J, Behler-Janbeck F, Baranowsky A, Schmidt T, Schwinge D, John C, Lohse AW, Schramm C, Heeren J, Schinke T, Amling M. Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients. Sci Rep. 2022;12:16491. https:\/\/doi.org\/10.1038\/s41598-022-20351-z.","journal-title":"Sci Rep"},{"key":"4379_CR63","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.bone.2009.11.021","volume":"46","author":"D Le Nihouannen","year":"2010","unstructured":"Le Nihouannen D, Barralet JE, Fong JE, Komarova SV. Ascorbic acid accelerates osteoclast formation and death. Bone. 2010;46:1336\u201343. https:\/\/doi.org\/10.1016\/j.bone.2009.11.021.","journal-title":"Bone"},{"key":"4379_CR64","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.3390\/ijms21124274","volume":"21","author":"TK Ahn","year":"2020","unstructured":"Ahn TK, Kim KT, Joshi HP, Park KH, Kyung JW, Choi UY, Sohn S, Sheen SH, Shin DE, Lee SH, Han IB. Therapeutic potential of tauroursodeoxycholic acid for the treatment of osteoporosis. Int J Mol Sci. 2020;21:4274. https:\/\/doi.org\/10.3390\/ijms21124274.","journal-title":"Int J Mol Sci"},{"key":"4379_CR65","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1021\/acsabm.1c00199","volume":"4","author":"C Jing","year":"2021","unstructured":"Jing C, Li B, Tan H, Zhang C, Liang H, Na H, Chen S, Liu C, Zhao L. Alendronate-decorated nanoparticles as bone-targeted alendronate carriers for potential osteoporosis treatment. ACS Appl Bio Mater. 2021;4:4907\u201316. https:\/\/doi.org\/10.1021\/acsabm.1c00199.","journal-title":"ACS Appl Bio Mater"},{"key":"4379_CR66","doi-asserted-by":"publisher","first-page":"216106","DOI":"10.1016\/j.canlet.2023.216106","volume":"558","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhu R, Zhou M, Liu J, Dong K, Zhao S, Cao J, Wang W, Sun C, Wu S, Wang F. Homologous cancer cell membrane-camouflaged nanoparticles target drug delivery and enhance the chemotherapy efficacy of hepatocellular carcinoma. Cancer Lett. 2023;558:216106. https:\/\/doi.org\/10.1016\/j.canlet.2023.216106.","journal-title":"Cancer Lett"},{"key":"4379_CR67","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.biomaterials.2018.08.018","volume":"185","author":"RJ Bose","year":"2018","unstructured":"Bose RJ, Kim BJ, Arai Y, Han IB, Moon JJ, Paulmurugan R, Park H, Lee SH. Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia. Biomaterials. 2018;185:360\u201370. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.08.018.","journal-title":"Biomaterials"},{"key":"4379_CR68","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3:1377\u201397. https:\/\/doi.org\/10.3390\/polym3031377.","journal-title":"Polymers"},{"key":"4379_CR69","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161:505\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2012.01.043.","journal-title":"J Control Release"},{"key":"4379_CR70","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/pi.1697","volume":"54","author":"F Alexis","year":"2005","unstructured":"Alexis F. Factors affecting the degradation and drug-release mechanism of poly (lactic acid) and poly [(lactic acid)\u2010co\u2010(glycolic acid)]. Polym Int. 2005;54:36\u201346. https:\/\/doi.org\/10.1002\/pi.1697.","journal-title":"Polym Int"},{"key":"4379_CR71","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/BF00701240","volume":"3","author":"M Vert","year":"1992","unstructured":"Vert M, Li SM, Spenlehauer G, Gu\u00e9rin P. Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci Mater Med. 1992;3:432\u201346. https:\/\/doi.org\/10.1007\/BF00701240.","journal-title":"J Mater Sci Mater Med"},{"issue":"1\u20132","key":"4379_CR72","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijpharm.2011.04.013","volume":"412","author":"T Seidenberger","year":"2011","unstructured":"Seidenberger T, Siepmann J, Bley H, Maeder K, Siepmann F. Simultaneous controlled vitamin release from multiparticulates: theory and experiment. Int J Pharm. 2011;412(1\u20132):68\u201376. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.04.013.","journal-title":"Int J Pharm"},{"key":"4379_CR73","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2217\/nnm.12.153","volume":"8","author":"S Aryal","year":"2013","unstructured":"Aryal S, Hu CMJ, Fang RH, Dehaini D, Carpenter C, Zhang DE, Zhang L. Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release. Nanomedicine. 2013;8:1271\u201380. https:\/\/doi.org\/10.2217\/nnm.12.153.","journal-title":"Nanomedicine"},{"key":"4379_CR74","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2147\/IJN.S195048","volume":"14","author":"MK Anwer","year":"2019","unstructured":"Anwer MK, Mohammad M, Ezzeldin E, Fatima F, Alalaiwe A, Iqbal M. Preparation of sustained-release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. Int J Nanomed. 2019;14:1587\u201395. https:\/\/doi.org\/10.2147\/IJN.S195048.","journal-title":"Int J Nanomed"},{"key":"4379_CR75","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4161\/cam.20888","volume":"6","author":"K Matsuo","year":"2012","unstructured":"Matsuo K, Otaki N. Bone cell interactions through Eph\/ephrin: bone modeling, remodeling and associated diseases. Cell Adhes Migr. 2012;6:148\u201356. https:\/\/doi.org\/10.4161\/cam.20888.","journal-title":"Cell Adhes Migr"},{"key":"4379_CR76","doi-asserted-by":"publisher","first-page":"110376","DOI":"10.1016\/j.cellsig.2022.110376","volume":"96","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Kou Y, Yang P, Rong X, Tang R, Liu H, Li M. ED-71 inhibited osteoclastogenesis by enhancing EphrinB2\u2013EphB4 signaling between osteoclasts and osteoblasts in osteoporosis. Cell Signal. 2022;96:110376. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110376.","journal-title":"Cell Signal"},{"key":"4379_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jconrel.2008.01.004","volume":"127","author":"BS Zolnik","year":"2008","unstructured":"Zolnik BS, Burgess DJ. Evaluation of in vivo\u2013in vitro release of dexamethasone from PLGA microspheres. J Control Release. 2008;127:137\u201345. https:\/\/doi.org\/10.1016\/j.jconrel.2008.01.004.","journal-title":"J Control Release"},{"key":"4379_CR78","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","volume":"9","author":"Q Xia","year":"2019","unstructured":"Xia Q, Zhang Y, Li Z, Hou X, Feng N. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Acta Pharm Sin B. 2019;9:675\u201389. https:\/\/doi.org\/10.1016\/j.apsb.2019.01.011.","journal-title":"Acta Pharm Sin B"},{"key":"4379_CR79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12951-021-01231-6","volume":"20","author":"C Zhang","year":"2022","unstructured":"Zhang C, Zhang W, Zhu D, Li Z, Wang Z, Li J, Mei X, Xu W, Cheng K, Zhong B. Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy. J Nanobiotechnol. 2022;20:35. https:\/\/doi.org\/10.1186\/s12951-021-01231-6.","journal-title":"J Nanobiotechnol"},{"key":"4379_CR80","doi-asserted-by":"publisher","first-page":"121438","DOI":"10.1016\/j.biomaterials.2022.121438","volume":"283","author":"Z Yang","year":"2022","unstructured":"Yang Z, Liu X, Zhao F, Yao M, Lin Z, Yang Z, Liu C, Liu Y, Chen X, Du C. Bioactive glass nanoparticles inhibit osteoclast differentiation and osteoporotic bone loss by activating lncRNA NRON expression in the extracellular vesicles derived from bone marrow mesenchymal stem cells. Biomaterials. 2022;283:121438. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121438.","journal-title":"Biomaterials"},{"key":"4379_CR81","doi-asserted-by":"publisher","first-page":"12511","DOI":"10.1074\/jbc.271.21.12511","volume":"271","author":"FH Drake","year":"1996","unstructured":"Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hastings G. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem. 1996;271:12511\u20136. https:\/\/doi.org\/10.1074\/jbc.271.21.12511.","journal-title":"J Biol Chem"},{"issue":"3","key":"4379_CR82","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0168-8278(01)00279-3","volume":"36","author":"CMP Rodrigues","year":"2002","unstructured":"Rodrigues CMP, Sol\u00e1 S, Brito MA, Brites D, Moura JJG. Bilirubin directly disrupts membrane lipid polarity and fluidity, protein order, and redox status in rat mitochondria. J Hepatol. 2002;36(3):335\u201341. https:\/\/doi.org\/10.1016\/S0168-8278(01)00279-3.","journal-title":"J Hepatol"},{"issue":"2","key":"4379_CR83","doi-asserted-by":"publisher","first-page":"020501","DOI":"10.11613\/BM.2025.020501","volume":"35","author":"I \u010cepelak","year":"2025","unstructured":"\u010cepelak I, Dodig S, Pavi\u0107 I. Bilirubin\u2013new insights into an old molecule. Biochem Med. 2025;35(2):020501. https:\/\/doi.org\/10.11613\/BM.2025.020501.","journal-title":"Biochem Med"},{"issue":"6","key":"4379_CR84","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41390-020-01156-0","volume":"89","author":"ST Kitchen","year":"2021","unstructured":"Kitchen ST, Tang N, He M, Ly E, Mooney SM, Bearer CF. Bilirubin inhibits lipid raft dependent functions of L1 cell adhesion molecule in rat pup cerebellar granule neurons. Pediatr Res. 2021;89(6):1389\u201395. https:\/\/doi.org\/10.1038\/s41390-020-01156-0.","journal-title":"Pediatr Res"},{"issue":"12","key":"4379_CR85","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/cells8121471","volume":"8","author":"M Kusaczuk","year":"2019","unstructured":"Kusaczuk M. Tauroursodeoxycholate\u2013bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives. Cells. 2019;8(12):1471. https:\/\/doi.org\/10.3390\/cells8121471.","journal-title":"Cells"},{"key":"4379_CR86","doi-asserted-by":"publisher","unstructured":"Hanafi NI, Mohamed AS, Sheikh Abdul Kadir SH, Othman MHD. Overview of bile acids signaling and perspective on the signal of ursodeoxycholic acid, the most hydrophilic bile acid, in the heart. Biomolecules, 8(4), 159. https:\/\/doi.org\/10.3390\/biom8040159","DOI":"10.3390\/biom8040159"},{"key":"4379_CR87","doi-asserted-by":"publisher","first-page":"102117","DOI":"10.1016\/j.nano.2019.102117","volume":"24","author":"AC Carit\u00e1","year":"2020","unstructured":"Carit\u00e1 AC, Fonseca\u2013Santos B, Shultz JD, Michniak\u2013Kohn B, Chorilli M, Leonardi GR, Vitamin C. One compound, several uses. Advances for delivery, efficiency and stability. Nanomed Nanotechnol Biol Med. 2020;24:102117. https:\/\/doi.org\/10.1016\/j.nano.2019.102117.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"4","key":"4379_CR88","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/emm.2003.38","volume":"35","author":"H Ha","year":"2003","unstructured":"Ha H, Kwak HB, Le SW, Kim HH, Lee ZH. Lipid rafts are important for the association of RANK and TRAF6. Exp Mol Med. 2003;35(4):279\u201384. https:\/\/doi.org\/10.1038\/emm.2003.38.","journal-title":"Exp Mol Med"},{"issue":"20","key":"4379_CR89","doi-asserted-by":"publisher","first-page":"18573","DOI":"10.1074\/jbc.M212626200","volume":"278","author":"H Ha","year":"2003","unstructured":"Ha H, Kwak HB, Lee SK, Na DS, Rudd CE, Lee ZH, Kim HH. Membrane rafts play a crucial role in receptor activator of nuclear factor \u03baB signaling and osteoclast function. J Biol Chem. 2003;278(20):18573\u201380. https:\/\/doi.org\/10.1074\/jbc.M212626200.","journal-title":"J Biol Chem"},{"key":"4379_CR90","doi-asserted-by":"publisher","first-page":"29240","DOI":"10.1038\/srep29240","volume":"6","author":"L Ziberna","year":"2016","unstructured":"Ziberna L, Martelanc M, Franko M, Passamonti S. Bilirubin is an endogenous antioxidant in human vascular endothelial cells. Sci Rep. 2016;6:29240. https:\/\/doi.org\/10.1038\/srep29240.","journal-title":"Sci Rep"},{"issue":"11","key":"4379_CR91","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/s0006-2952(02)01391-6","volume":"64","author":"D Lapenna","year":"2002","unstructured":"Lapenna D, Ciofani G, Festi D, Neri M, Pierdomenico SD, Giamberardino MA, Cuccurullo F. Antioxidant properties of ursodeoxycholic acid. Biochem Pharmacol. 2002;64(11):1661\u20137. https:\/\/doi.org\/10.1016\/s0006-2952(02)01391-6.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"4379_CR92","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.2174\/1570159X21666230907152207","volume":"22","author":"J Li","year":"2024","unstructured":"Li J, Huang Z, Jin Y, Liang L, Li Y, Xu K, Zhou W, Li X. Neuroprotective effect of tauroursodeoxycholic acid (TUDCA) on in vitro and in vivo models of retinal disorders: a systematic review. Curr Neuropharmacol. 2024;22(8):1374\u201390.","journal-title":"Curr Neuropharmacol"},{"key":"4379_CR93","doi-asserted-by":"publisher","unstructured":"[102]. Oh S, Kim YJ, Lee EK, Park SW, Yu HG. Antioxidative effects of ascorbic acid and astaxanthin on ARPE\u201319 cells in an oxidative stress model. Antioxidants. 2020;9(9):833. https:\/\/doi.org\/10.3390\/antiox9090833.","DOI":"10.3390\/antiox9090833"},{"key":"4379_CR94","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fphar.2012.00045","volume":"3","author":"SY Kim","year":"2012","unstructured":"Kim SY, Park SC. Physiological antioxidative network of the bilirubin system in aging and age-related diseases. Front Pharmacol. 2012;3:45. https:\/\/doi.org\/10.3389\/fphar.2012.00045.","journal-title":"Front Pharmacol"},{"key":"4379_CR95","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.3390\/ijms20143576","volume":"20","author":"TS Agidigbi","year":"2019","unstructured":"Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int J Mol Sci. 2019;20:3576. https:\/\/doi.org\/10.3390\/ijms20143576.","journal-title":"Int J Mol Sci"},{"key":"4379_CR96","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1186\/s12891-022-05592-3","volume":"23","author":"J Wu","year":"2022","unstructured":"Wu J, Su J, Wang Y, Chen J, Shang Y, Li J. Association between total bilirubin and bone mineral density level in adolescents. BMC Musculoskelet Disord. 2022;23:639. https:\/\/doi.org\/10.1186\/s12891-022-05592-3.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"4379_CR97","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K","volume":"57","author":"U Mayr\u2013Wohlfart","year":"2001","unstructured":"Mayr\u2013Wohlfart U, Fiedler J, G\u00fcnther KP, Puhl W, Kessler S. Proliferation and differentiation rates of a human osteoblast\u2013like cell line (SaOS\u20132) in contact with different bone substitute materials. J Biomed Mater Res. 2001;57(1):132\u20139. https:\/\/doi.org\/10.1002\/1097-4636(200110)57:1%3C132::aid-jbm1152%3E3.0.co;2-k.","journal-title":"J Biomed Mater Res"},{"issue":"1","key":"4379_CR98","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12011-013-9770-0","volume":"155","author":"L Huo","year":"2013","unstructured":"Huo L, Liu K, Pei J, Yang Y, Ye Y, Liu Y, Sun J, Han H, Xu W, Gao Y. Fluoride promotes viability and differentiation of osteoblast\u2013like SaOS\u20132 cells via BMP\/Smads signaling pathway. Biol Trace Elem Res. 2013;155(1):142\u20139. https:\/\/doi.org\/10.1007\/s12011-013-9770-0.","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"4379_CR99","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2353\/ajpath.2010.090755","volume":"176","author":"V Krasnoperov","year":"2010","unstructured":"Krasnoperov V, Kumar SR, Ley E, Li X, Scehnet J, Liu R, Zozulya S, Gill PS. Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth. Am J Pathol. 2010;176(4):2029\u201338. https:\/\/doi.org\/10.2353\/ajpath.2010.090755.","journal-title":"Am J Pathol"},{"issue":"2","key":"4379_CR100","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4161\/cam.19620","volume":"6","author":"R Noberini","year":"2012","unstructured":"Noberini R, de la Rubio E, Pasquale EB. Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach. Cell Adh Migr. 2012;6(2):102\u201312. https:\/\/doi.org\/10.4161\/cam.19620.","journal-title":"Cell Adh Migr"},{"key":"4379_CR101","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1021\/la103576a","volume":"26","author":"RH Fang","year":"2010","unstructured":"Fang RH, Aryal S, Hu CMJ, Zhang L. Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir. 2010;26:16958\u201362. https:\/\/doi.org\/10.1021\/la103576a.","journal-title":"Langmuir"},{"key":"4379_CR102","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3:1377\u201397. https:\/\/doi.org\/10.3390\/polym3031377.","journal-title":"Polymers"},{"key":"4379_CR103","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161:505\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2012.01.043.","journal-title":"J Control Release"},{"issue":"11","key":"4379_CR104","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1021\/acsbiomaterials.0c01228","volume":"6","author":"J Yoo","year":"2020","unstructured":"Yoo J, Won YY. Phenomenology of the initial burst release of drugs from PLGA microparticles. ACS Biomater Sci Eng. 2020;6(11):6053\u201362. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c01228.","journal-title":"ACS Biomater Sci Eng"},{"issue":"12","key":"4379_CR105","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1007\/s11095-017-2257-5","volume":"34","author":"SK Paswan","year":"2020","unstructured":"Paswan SK, Saini TR. Purification of drug loaded PLGA nanoparticles prepared by emulsification solvent evaporation using stirred cell ultrafiltration technique. Pharm Res. 2020;34(12):2779\u201386. https:\/\/doi.org\/10.1007\/s11095-017-2257-5.","journal-title":"Pharm Res"},{"key":"4379_CR106","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/pi.1697","volume":"54","author":"F Alexis","year":"2005","unstructured":"Alexis F. Factors affecting the degradation and drug-release mechanism of poly (lactic acid) and poly [(lactic acid)\u2010co\u2010(glycolic acid)]. Polym Int. 2005;54:36\u201346. https:\/\/doi.org\/10.1002\/pi.1697.","journal-title":"Polym Int"},{"key":"4379_CR107","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/BF00701240","volume":"3","author":"M Vert","year":"1992","unstructured":"Vert M, Li SM, Spenlehauer G, Gu\u00e9rin P. Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci Mater Med. 1992;3:432\u201346. https:\/\/doi.org\/10.1007\/BF00701240.","journal-title":"J Mater Sci Mater Med"},{"key":"4379_CR108","doi-asserted-by":"publisher","first-page":"113625","DOI":"10.1016\/j.jconrel.2025.113625","volume":"381","author":"S Lee","year":"2025","unstructured":"Lee S, Kim B, Lee MJ, Kim D, Park S, Kim J, Arai Y, Lee SH. Curcumin-PLGA NPs coated with targeting biomimetic personalized stem cell membranes for osteoarthritis therapy. J Control Release. 2025;381:113625. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113625.","journal-title":"J Control Release"},{"key":"4379_CR109","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","volume":"13","author":"H Liu","year":"2023","unstructured":"Liu H, Su YY, Jiang XC, Gao JQ. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system. Drug Deliv Transl Res. 2023;13:716\u201337. https:\/\/doi.org\/10.1007\/s13346-022-01252-0.","journal-title":"Drug Deliv Transl Res"},{"key":"4379_CR110","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrendo.2013.179","volume":"9","author":"SC Manolagas","year":"2013","unstructured":"Manolagas SC, O\u2019Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013;9:699. https:\/\/doi.org\/10.1038\/nrendo.2013.179.","journal-title":"Nat Rev Endocrinol"},{"key":"4379_CR111","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/cancers11050640","volume":"11","author":"J Yoo","year":"2019","unstructured":"Yoo J, Park C, Yi G, Lee D, Koo H. Active targeting strategies using biological ligands for nanoparticle drug delivery systems. Cancers. 2019;11:640. https:\/\/doi.org\/10.3390\/cancers11050640.","journal-title":"Cancers"},{"key":"4379_CR112","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12951-024-02835-4","volume":"22","author":"M Mengyuan","year":"2024","unstructured":"Mengyuan M, Aixue A, Yongwei G, Qingqing C, Huanhuan C, Xiaoyan L, Jiyong L. Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication. J Nanobiotechnol. 2024;22:604. https:\/\/doi.org\/10.1186\/s12951-024-02835-4.","journal-title":"J Nanobiotechnol"},{"key":"4379_CR113","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/978-3-319-99375-1_64","volume":"2","author":"L Ginaldi","year":"2005","unstructured":"Ginaldi L, Di Benedetto MC, De Martinis M. Osteoporosis, inflammation and ageing, Immun. Ageing. 2005;2:14. https:\/\/doi.org\/10.1007\/978-3-319-99375-1_64.","journal-title":"Ageing"},{"key":"4379_CR114","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","volume":"11","author":"JA Nagy","year":"2008","unstructured":"Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis. 2008;11:109\u201319. https:\/\/doi.org\/10.1007\/s10456-008-9099-z.","journal-title":"Angiogenesis"},{"key":"4379_CR115","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.7150\/thno.103636","volume":"15","author":"X Shao","year":"2025","unstructured":"Shao X, Zhao X, Wang B, Fan J, Wang J, An H. Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy. Theranostics. 2025;15:1689\u2013714. https:\/\/doi.org\/10.7150\/thno.103636.","journal-title":"Theranostics"},{"key":"4379_CR116","doi-asserted-by":"publisher","first-page":"216397","DOI":"10.1016\/j.canlet.2023.216397","volume":"574","author":"M Xu","year":"2023","unstructured":"Xu M, Li S. Nano-drug delivery system targeting tumor microenvironment: a prospective strategy for melanoma treatment. Cancer Lett. 2023;574:216397. https:\/\/doi.org\/10.1016\/j.canlet.2023.216397.","journal-title":"Cancer Lett"},{"key":"4379_CR117","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fchem.2020","volume":"8","author":"H Liu","year":"2020","unstructured":"Liu H, Yao J, Guo H, Cai X, Jiang Y, Lin M, Jiang X, Leung W, Xu C. Tumor microenvironment-responsive nanomaterials as targeted delivery carriers for photodynamic anticancer therapy. Front Chem. 2020;8:758. https:\/\/doi.org\/10.3389\/fchem.2020.","journal-title":"Front Chem"},{"key":"4379_CR118","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/antiox10101536","volume":"10","author":"CA Adin","year":"2021","unstructured":"Adin CA. Bilirubin as a therapeutic molecule: challenges and opportunities. Antioxidants. 2021;10:1536. https:\/\/doi.org\/10.3390\/antiox10101536.","journal-title":"Antioxidants"},{"key":"4379_CR119","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman DG, Mundy GR, Boyce BF. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Min Res. 1995;10:1478\u201387. https:\/\/doi.org\/10.1002\/jbmr.5650101008.","journal-title":"J Bone Min Res"},{"key":"4379_CR120","doi-asserted-by":"publisher","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","volume":"21","author":"JH Kim","year":"2014","unstructured":"Kim JH, Kim N. Regulation of NFATc1 in osteoclast differentiation. J Bone Metab. 2014;21:233\u201341. https:\/\/doi.org\/10.11005\/jbm.2014.21.4.233.","journal-title":"J Bone Metab"},{"key":"4379_CR121","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/jemt.10374","volume":"61","author":"JM Delaiss\u00e9","year":"2003","unstructured":"Delaiss\u00e9 JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech. 2003;61:504\u201313. https:\/\/doi.org\/10.1002\/jemt.10374.","journal-title":"Microsc Res Tech"},{"key":"4379_CR122","doi-asserted-by":"publisher","first-page":"101114","DOI":"10.1016\/j.bonr.2021.101114","volume":"15","author":"K Yasuda","year":"2021","unstructured":"Yasuda K, Matsubara T, Shirakawa T, Kawamoto T, Kokabu S. Protein phosphatase 1 regulatory subunit 18 suppresses the transcriptional activity of NFATc1 via regulation of c-fos. Bone Rep. 2021;15:101114. https:\/\/doi.org\/10.1016\/j.bonr.2021.101114.","journal-title":"Bone Rep"},{"key":"4379_CR123","doi-asserted-by":"publisher","first-page":"d757","DOI":"10.2741\/a319","volume":"3","author":"LT Duong","year":"1998","unstructured":"Duong LT, Rodan GA. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation. Front Biosci. 1998;3:d757\u201368. https:\/\/doi.org\/10.2741\/a319.","journal-title":"Front Biosci"},{"key":"4379_CR124","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/jcp.25389","volume":"231","author":"YH Chiu","year":"2016","unstructured":"Chiu YH, Ritchlin CT. DC-STAMP: a key regulator in osteoclast differentiation. J Cell Physiol. 2016;231:2402\u20137. https:\/\/doi.org\/10.1002\/jcp.25389.","journal-title":"J Cell Physiol"},{"key":"4379_CR125","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/pharmaceutics17060689","volume":"17","author":"SA Dragulska","year":"2025","unstructured":"Dragulska SA, Acosta Santiago M, Swierczek S, Chuang L, Camacho-Vanegas O, Camacho SC, Padron-Rhenals MM, Martignetti JA, Mieszawska AJ. Synthesis and Characterization of Poly(Lactic-Co-Glycolic Acid)\u2013Paclitaxel (PLGA-PTX) Nanoparticles Evaluated in Ovarian Cancer Models. Pharmaceutics. 2025;17:689. https:\/\/doi.org\/10.3390\/pharmaceutics17060689.","journal-title":"Pharmaceutics"},{"key":"4379_CR126","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/pharmaceutics11040184","volume":"11","author":"H Yang","year":"2019","unstructured":"Yang H, Li J, Patel SK, Palmer KE, Devlin B, Rohan LC. Design of poly(Lactic-Co-Glycolic Acid) (PLGA) nanoparticles for vaginal co-delivery of griffithsin and dapivirine and their synergistic effect for HIV prophylaxis. Pharmaceutics. 2019;11:184. https:\/\/doi.org\/10.3390\/pharmaceutics11040184.","journal-title":"Pharmaceutics"},{"key":"4379_CR127","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2147\/nano.2006.1.4.541","volume":"1","author":"H Liu","year":"2006","unstructured":"Liu H, Slamovich EB, Webster TJ. Less harmful acidic degradation of poly(Lactic-Co-Glycolic Acid) bone tissue engineering scaffolds through titania nanoparticle addition. Int J Nanomed. 2006;1:541\u20135. https:\/\/doi.org\/10.2147\/nano.2006.1.4.541.","journal-title":"Int J Nanomed"},{"key":"4379_CR128","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1096\/fj.14-254300","volume":"28","author":"S Tonna","year":"2014","unstructured":"Tonna S, Takyar FM, Vrahnas C, Crimeen-Irwin B, Ho PW, Poulton IJ, Brennan HJ, McGregor NE, Allan EH, Nguyen H, Forwood MR. EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis. FASEB J. 2014;28:4482\u201396. https:\/\/doi.org\/10.1096\/fj.14-254300.","journal-title":"FASEB J"},{"key":"4379_CR129","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s40610-015-0024-0","volume":"1","author":"C Vrahnas","year":"2015","unstructured":"Vrahnas C, Sims NA. EphrinB2 signalling in osteoblast differentiation, bone formation and endochondral ossification. Curr Mol Biol Rep. 2015;1:148\u201356. https:\/\/doi.org\/10.1007\/s40610-015-0024-0.","journal-title":"Curr Mol Biol Rep"},{"key":"4379_CR130","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fbioe.2020.00627","volume":"8","author":"M Sushnitha","year":"2020","unstructured":"Sushnitha M, Evangelopoulos M, Tasciotti E, Taraballi F. Cell membrane-based biomimetic nanoparticles and the immune system: immunomodulatory interactions to therapeutic applications. Front Bioeng Biotechnol. 2020;8:627. https:\/\/doi.org\/10.3389\/fbioe.2020.00627.","journal-title":"Front Bioeng Biotechnol"},{"key":"4379_CR131","doi-asserted-by":"publisher","unstructured":"Knop JL, Burkard N, Danesh M, Kintrup S, Dandekar T, Srivastava M, Springer R, Hiermaier M, Wagner NM, Waschke J, Flemming S. Endothelial barrier dysfunction in systemic inflammation is mediated by soluble VE-cadherin interfering with VE-PTP signaling, iScience 26 (2023) 107698. https:\/\/doi.org\/10.1016\/j.isci.2023.108049","DOI":"10.1016\/j.isci.2023.108049"},{"key":"4379_CR132","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1067\/msy.2002.125305","volume":"132","author":"FE Nwariaku","year":"2002","unstructured":"Nwariaku FE, Liu Z, Zhu X, Turnage RH, Sarosi GA, Terada LS. Tyrosine phosphorylation of vascular endothelial cadherin and the regulation of microvascular permeability. Surgery. 2002;132:180\u20135. https:\/\/doi.org\/10.1067\/msy.2002.125305.","journal-title":"Surgery"},{"key":"4379_CR133","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bonr.2018.06.007","volume":"9","author":"KB Farrell","year":"2018","unstructured":"Farrell KB, Karpeisky A, Thamm DH, Zinnen S. Bisphosphonate conjugation for bone-specific drug targeting. Bone Rep. 2018;9:47\u201360. https:\/\/doi.org\/10.1016\/j.bonr.2018.06.007.","journal-title":"Bone Rep"},{"key":"4379_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"X Pang","year":"2023","unstructured":"Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z, Gu Y, Zhao N, Xiang Q, Cui Y. Targeting integrin pathways: mechanisms and advances in therapy, Signal Transduct. Target Ther. 2023;8:1. https:\/\/doi.org\/10.1038\/s41392-022-01259-6.","journal-title":"Target Ther"},{"key":"4379_CR135","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/jbmr.1475","volume":"27","author":"PJ Masarachia","year":"2012","unstructured":"Masarachia PJ, Pennypacker BL, Pickarski M, Scott KR, Wesolowski GA, Smith SY, Samadfam R, Goetzmann JE, Scott BB, Kimmel DB, Duong LT. Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys. J Bone Min Res. 2012;27:509\u201323. https:\/\/doi.org\/10.1002\/jbmr.1475.","journal-title":"J Bone Min Res"},{"key":"4379_CR136","first-page":"15788","volume":"9","author":"YT Jiang","year":"2016","unstructured":"Jiang YT, Ma ZG, Jiao JB, Guo Z, Qian LG, Chen TP, Li QG, Wang YF, Xue JW. Cathepsin K inhibitor, icariin, increases the healing potential and biomechanical properties of femoral neck in a mice fractured model. Int J Clin Exp Med. 2016;9:15788\u201395.","journal-title":"Int J Clin Exp Med"},{"key":"4379_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bonr.2018.05.006","volume":"9","author":"H Yamashita","year":"2018","unstructured":"Yamashita H, Hagino I, Hayashi M, Hayashibara A, Tanida K, Nagira R, Fukui H, Nagashima. Effect of a cathepsin K inhibitor on arthritis and bone mineral density in ovariectomized rats with collagen-induced arthritis. Bone Rep. 2018;9:1\u201310. https:\/\/doi.org\/10.1016\/j.bonr.2018.05.006.","journal-title":"Bone Rep"},{"key":"4379_CR138","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.actbio.2020.12.047","volume":"122","author":"YZ Zhao","year":"2021","unstructured":"Zhao YZ, Huang ZW, Zhai YY, Shi Y, Du CC, Zhai J, Xu HL, Xiao J, Kou L, Yao Q. Polylysine\u2013bilirubin conjugates maintain functional islets and promote M2 macrophage polarization. Acta Biomater. 2021;122:172\u201385. https:\/\/doi.org\/10.1016\/j.actbio.2020.12.047.","journal-title":"Acta Biomater"},{"key":"4379_CR139","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2001","unstructured":"Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2001;7:292\u2013304. https:\/\/doi.org\/10.1038\/nri2062.","journal-title":"Nat Rev Immunol"},{"key":"4379_CR140","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1210\/er.2007-0038","volume":"29","author":"J Lorenzo","year":"2008","unstructured":"Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008;29:403\u201340.","journal-title":"Endocr Rev"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04379-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04379-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04379-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:22:54Z","timestamp":1779668574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04379-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4379"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04379-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were conducted in compliance with relevant laws and guidelines and approved by the Korean Institutional Animal Care and Use Committee (IACUC, approval number: IACUC-2023-014-2). No human participants were involved; therefore, consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"466"}}